BioTech Medics, Inc. announced that it has signed a $5 million U.S. cross-marketing licensing non-exclusive contract for its patented SHBAN Alcohol Free Persistent Hand & Body Sanitizer with LifeBionix, Inc. The agreement includes cash and ongoing royalties payable to BioTech over a five year term anticipated to start third quarter 2013 without dilution of BioTech stock.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.016 USD | -30.43% |
|
-33.33% | -55.43% |
2015 | BioTech Medics Opens BioTech Laser Center in Keller, Texas | CI |
2013 | BioTech Medics, Inc. Signs $5 Million Cross-Marketing Licensing Agreement with LifeBionix, Inc | CI |
1st Jan change | Capi. | |
---|---|---|
-55.43% | 4.65M | |
-2.79% | 116B | |
+3.37% | 95.7B | |
+26.70% | 67.56B | |
+8.30% | 64.16B | |
+16.23% | 44.95B | |
+14.23% | 42.32B | |
+25.77% | 36.39B | |
+6.42% | 25.42B | |
-4.65% | 22.16B |
- Stock Market
- Equities
- BMCS Stock
- News BioTech Medics, Inc.
- BioTech Medics, Inc. Signs $5 Million Cross-Marketing Licensing Agreement with LifeBionix, Inc